Keeping Track: Clovis Completes NDA; FDA Clears 3D-Printed Antiepileptic But Declines Preservative-Free Eye Drug
The latest drug development news and highlights from our FDA Performance Tracker.
You may also be interested in...
Agency documents its regulatory science accomplishments to advance product development and manufacturing and ensure the safety and effectiveness of marketed products.
Two required confirmatory studies will bolster application that relied on historical controls for orphan neurodegenerative disease.
Keeping Track: Terliprez, Sotyktu Keep Up US FDA’s Novel Approvals Pace; Submissions By Pfizer, Chiesi And BioLineRx
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker